Skip to main content

Agilent Obtains Abbott License to Make, Sell Microarrays for Expression, CGH Apps

NEW YORK (GenomeWeb News) – Agilent today said Abbott Molecular has granted it a license to manufacture, market, and sell oligonucleotide microarrays using a two-or-more color technology for gene expression and comparative genomic hybridization applications.

The worldwide, non-exclusive license covers the use of microarrays for research, commercial labs, and in vitro diagnostic applications.

 
Financial details were not disclosed.